Home › Endometrial Cancer › District of Columbia
Endometrial Cancer clinical trials in District of Columbia
10 studies for Endometrial Cancer are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- MedStar Washington Hospital Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 5, 2026 · NCT07198074Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Georgetown University Medical Center, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- MedStar Washington Hospital Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT06340568A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- MedStar Washington Hospital Center ( Site 5005), Washington D.C.
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT06952504Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- MedStar Washington Hospital, Washington D.C.
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 9, 2026 · NCT07166094A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Georgetown University Medical Center, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07227168Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's National Medical Center, Washington D.C.
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07182149FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Washington D.C.
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.